Cadrenal Therapeutics, Inc. Common Stock (CVKD) ownership: Top institutional holder: VANGUARD GROUP INC ($365524.00). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| VANGUARD GROUP INC | 53912.00 | $365524.00 | 2025-12-31 |
| CITADEL ADVISORS LLC | 19864.00 | $273627.00 | 2025-09-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 45201.00 | $231429.00 | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 21626.00 | $110724.00 | 2026-03-31 |
| LPL Financial LLC | 13000.00 | $88140.00 | 2025-12-31 |
| VANGUARD FIDUCIARY TRUST CO | 8311.00 | $42552.00 | 2026-03-31 |
| JPMORGAN CHASE & CO | 7500.00 | $31875.00 | 2026-03-31 |
| BlackRock, Inc. | 5496.00 | $28140.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-29 | |
| Sell | null | 2026-06-25 | |
| Sell | null | 2026-06-25 | |
| Sell | null | 2026-06-22 | |
| Sell | null | 2026-06-22 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-11 |
Back to CVKD overview · CVKD earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.